Literature DB >> 26884868

MAPK1 up-regulates the expression of MALAT1 to promote the proliferation of cardiomyocytes through PI3K/AKT signaling pathway.

Jing Zhao1, Li Li1, Ling Peng1.   

Abstract

The previous studies identify mammalian heart is terminal differentiation organs without regenerative capacity. Recently, there is some evidence point that cardiomyocytes are not terminally differentiated cells and cell proliferation may be stimulated in the pathologic heart. The aim of this study is to discover the possible mechanism which involved in cardiomyocytes proliferation process. In this study, the proliferation assay and cell cycle assay showed the proliferation of cardiomyocytes was inhibited when the cells treated with MAPK1 inhibitor. Moreover, the bioinformatics analysis revealed MAPK1 was positively correlated with MALAT1. Meanwhile, the expression of MALAT1 in H9C2 cells with the treatment of MAPK1 siRNA was obvious lower than scramble siRNA treated group. Finally further study suggested H9C2 cells treated with Wortmannin in combination with LY294002 (PI3K/AKT signaling pathway inhibitor), the expression of MALAT1 was dramatically decreased. These results indicated that MAPK1 was able to increase the proliferation of cardiomyocytes via up-regulating the expression of MALAT1 through PI3K/AKT signaling pathway.

Entities:  

Keywords:  Cardiomyocytes; MALAT1; MAPK1; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26884868      PMCID: PMC4730081     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  30 in total

1.  ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth.

Authors:  Jian Zhao; Xuejun Yuan; Morten Frödin; Ingrid Grummt
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

2.  Adult cardiac stem cells are multipotent and support myocardial regeneration.

Authors:  Antonio P Beltrami; Laura Barlucchi; Daniele Torella; Mathue Baker; Federica Limana; Stefano Chimenti; Hideko Kasahara; Marcello Rota; Ezio Musso; Konrad Urbanek; Annarosa Leri; Jan Kajstura; Bernardo Nadal-Ginard; Piero Anversa
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

3.  Left ventricular hypertrophy: a cytometric study on 42 human hearts.

Authors:  E Astorri; R Bolognesi; B Colla; A Chizzola; O Visioli
Journal:  J Mol Cell Cardiol       Date:  1977-09       Impact factor: 5.000

4.  MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.

Authors:  Yongqiang Dong; Guojun Liang; Bo Yuan; Chaoqun Yang; Rui Gao; Xuhui Zhou
Journal:  Tumour Biol       Date:  2014-11-28

5.  MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes.

Authors:  W Zhu; Y Zou; R Aikawa; K Harada; S Kudoh; H Uozumi; D Hayashi; Y Gu; T Yamazaki; R Nagai; Y Yazaki; I Komuro
Journal:  Circulation       Date:  1999-11-16       Impact factor: 29.690

6.  Extracellular signal-regulated kinases in T cells: characterization of human ERK1 and ERK2 cDNAs.

Authors:  H Owaki; R Makar; T G Boulton; M H Cobb; T D Geppert
Journal:  Biochem Biophys Res Commun       Date:  1992-02-14       Impact factor: 3.575

7.  Nuclear localization and regulation of erk- and rsk-encoded protein kinases.

Authors:  R H Chen; C Sarnecki; J Blenis
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

Review 8.  The role of coronary artery lesions in ischemic heart disease: insights from recent clinicopathologic, coronary arteriographic, and experimental studies.

Authors:  L M Buja; J T Willerson
Journal:  Hum Pathol       Date:  1987-05       Impact factor: 3.466

9.  Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients.

Authors:  W C Roberts; R J Siegel; B M McManus
Journal:  Am J Cardiol       Date:  1987-12-01       Impact factor: 2.778

10.  MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo.

Authors:  Daniel J Lips; Orlando F Bueno; Benjamin J Wilkins; Nicole H Purcell; Robert A Kaiser; John N Lorenz; Laure Voisin; Marc K Saba-El-Leil; Sylvain Meloche; Jacques Pouysségur; Gilles Pagès; Leon J De Windt; Pieter A Doevendans; Jeffery D Molkentin
Journal:  Circulation       Date:  2004-04-19       Impact factor: 29.690

View more
  19 in total

Review 1.  The crosstalk between long non-coding RNAs and PI3K in cancer.

Authors:  Leonidas Benetatos; Evangelos Voulgaris; Georgios Vartholomatos
Journal:  Med Oncol       Date:  2017-02-07       Impact factor: 3.064

2.  Integrative gene ontology and network analysis of coronary artery disease associated genes suggests potential role of ErbB pathway gene EGFR.

Authors:  Madankumar Ghatge; Jiny Nair; Ankit Sharma; Rajani Kanth Vangala
Journal:  Mol Med Rep       Date:  2018-01-08       Impact factor: 2.952

3.  Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.

Authors:  Hilda Samimi; Vahid Haghpanah; Shiva Irani; Ehsan Arefian; Alireza Naderi Sohi; Parviz Fallah; Masoud Soleimani
Journal:  Daru       Date:  2019-05-10       Impact factor: 3.117

4.  Association of the Genetic Variation in the Long Non-Coding RNA FENDRR with the Risk of Developing Hypertrophic Cardiomyopathy.

Authors:  Elías Cuesta-Llavona; Rebeca Lorca; Valeria Rolle; Belén Alonso; Sara Iglesias; Julian Rodríguez-Reguero; Israel David Duarte-Herrera; Sergio Pérez-Oliveira; Alejandro Junco-Vicente; Claudia García Lago; Eliecer Coto; Juan Gómez
Journal:  Life (Basel)       Date:  2022-05-30

5.  A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report.

Authors:  Suning Chen; Stefan Nagel; Bjoern Schneider; Haiping Dai; Robert Geffers; Maren Kaufmann; Corinna Meyer; Claudia Pommerenke; Kenneth S Thress; Jiao Li; Hilmar Quentmeier; Hans G Drexler; Roderick A F MacLeod
Journal:  Cell Oncol (Dordr)       Date:  2017-11-08       Impact factor: 6.730

6.  [Mechanism and material basis of Lianhua Qingwen capsule for improving clinical cure rate of COVID-19: a study based on network pharmacology and molecular docking technology].

Authors:  Haiyan Yan; Chuncai Zou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

7.  The protective value of miR-204-5p for prognosis and its potential gene network in various malignancies: a comprehensive exploration based on RNA-seq high-throughput data and bioinformatics.

Authors:  Zhi-Hua Ye; Dong-Yue Wen; Xiao-Yong Cai; Liang Liang; Pei-Rong Wu; Hui Qin; Hong Yang; Yun He; Gang Chen
Journal:  Oncotarget       Date:  2017-10-23

8.  Profiling of Long Non-coding RNAs and mRNAs by RNA-Sequencing in the Hippocampi of Adult Mice Following Propofol Sedation.

Authors:  Jun Fan; Quan Zhou; Yan Li; Xiuling Song; Jijie Hu; Zaisheng Qin; Jing Tang; Tao Tao
Journal:  Front Mol Neurosci       Date:  2018-03-23       Impact factor: 5.639

Review 9.  Long non-coding RNAs in ischemic stroke.

Authors:  Mei-Hua Bao; Vivian Szeto; Burton B Yang; Shu-Zhen Zhu; Hong-Shuo Sun; Zhong-Ping Feng
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469

Review 10.  LncRNAs in genetic basis of glaucoma.

Authors:  Yacouba Cissé; Lang Bai; Ting Meng
Journal:  BMJ Open Ophthalmol       Date:  2018-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.